Flow cytometry analysis of cellROX green reagent, a marker of ROS, revealed that cellROX mean intensity was distinctly higher in CD14+ cells, CD4+ T-cells, and CD8+ T-cells from individuals with T2DM compared to healthy volunteers (Fig. 7A-C). This evidence concerns the gene CD8A and type 2 diabetes mellitus.